Claim Language as a Determining Factor in Patent Infringement Litigation
Whilst patent litigation remains a priority target for many funders, … An LFJ Conversation with Ed Reilly, Cofounder, Themis Legal Capital.
Archive for April, 2023
-
In: PATENT NEWS
-
In: PATENT NEWS
Claim Language as a Determining Factor in Patent Infringement … – Litigation Finance Journal
Claim Language as a Determining Factor in Patent Infringement … Litigation Finance Journal
-
In: TRADEMARK NEWS
If a Good is not a Good, then a Trademark is not a Trademark … – JD Supra
If a Good is not a Good, then a Trademark is not a Trademark … JD Supra
-
In: PATENT NEWS
Ultimovacs Receives Intention to Grant Notice on European Patent on UV1 Cancer Vaccine …
Corresponding patent granted in the US, additional applications pending Oslo … pursuant to Section 5-12 in the Norwegian Securities Trading Act.
-
In: TRADEMARK NEWS
SCOTUS Set to Address United States Trademark Law’s … – JD Supra
SCOTUS Set to Address United States Trademark Law’s … JD Supra
-
In: PATENT NEWS
USPTO to Launch New Patent Issue Procedure on April 18: What … – JD Supra
USPTO to Launch New Patent Issue Procedure on April 18: What … JD Supra
-
In: PATENT NEWS
Evergreening in the world of finance and patents – Free Press Journal
Evergreening in the world of finance and patents Free Press Journal
-
In: PATENT NEWS
Jordan Altman Joins Ropes & Gray in New York
In the highly competitive world of intellectual property, Ropes & Gray’s IP attorneys are regularly recognized for their legal acumen by Chambers, …
-
In: PATENT NEWS
Recent Developments in the Application of Estoppel in Patent Proceedings – Duane Morris
Inter partes review (IPR) before the Patent Trial and Appeal Board (PTAB) … asserting that common-law claim preclusion barred Intel from …
-
In: PATENT NEWS
Lantern Pharma to Receive US Patent for Drug Candidate LP-284 – Marketscreener.com
Lantern Pharma to Receive US Patent for Drug Candidate LP-284 Marketscreener.com